Immunization

iBio Announces Progression of Vaccine Program for Multi-Variant COVID-19 Disease

Retrieved on: 
Wednesday, January 26, 2022 - 2:00pm

iBio recently received the U.S. Food and Drug Administrations (FDA) response to its pre-investigational new drug (IND) package for IBIO-202.

Key Points: 
  • iBio recently received the U.S. Food and Drug Administrations (FDA) response to its pre-investigational new drug (IND) package for IBIO-202.
  • In November 2020, iBio began exploring a second-generation COVID vaccine program based upon the nucleocapsid protein.
  • Today, iBio announced that, based on feedback it has received from the FDA, it will pursue IND-enabling studies for IBIO-202.
  • More information on the COVID-19 vaccine program can be found on the Companys website .

VIKING MARKS FLOAT OUT OF NEWEST EGYPT SHIP

Retrieved on: 
Thursday, January 27, 2022 - 4:00pm

LOS ANGELES, Jan. 27, 2022 /PRNewswire/ -- Viking® (www.viking.com) today announced its newest ship for the Nile River—the 82-guest Viking Osiris—was "floated out," marking a major construction milestone and the first time the ship has touched water. Set to debut in August 2022, Viking Osiris will sail Viking's bestselling 12-day Pharaohs & Pyramids itinerary. The arrival of Viking's new ship later this year coincides with several key events in Egypt in 2022, including the highly anticipated opening of the new Grand Egyptian Museum outside Cairo on the Giza Plateau—as well as the 100th anniversary of the discovery of King Tutankhamen's tomb by Howard Carter and his benefactor, the 5th Earl of Carnarvon. Building on Viking's longstanding relationship with the Carnarvon family, guests who sail on board Viking Osiris will experience Privileged Access® to memories from 1922 and the events surrounding the discovery of King Tutankhamen's tomb.

Key Points: 
  • LOS ANGELES, Jan. 27, 2022 /PRNewswire/ --Viking ( www.viking.com ) today announced its newest ship for the Nile Riverthe 82-guest Viking Osiris was "floated out," marking a major construction milestone and the first time the ship has touched water.
  • Particularly during this milestone year for Egypt, we look forward to welcoming guests on board Viking Osiris and introducing them to the country's many cultural treasures."
  • Viking Osiris will join the company's other ship on the Nile, Viking Ra, which launched in 2018.
  • Additionally, in response to strong demand, Viking Aton, an identical sister ship to Viking Osiris, will join the fleet in 2023.

Global Pediatric Vaccines Market Forecast 2022-2027, Featuring GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur and CSL - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 26, 2022 - 10:01am

The "Pediatric Vaccines Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pediatric Vaccines Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The Global Pediatric Vaccines Market is expected to reach USD 62 Billion in 2027.
  • In this huge market of vaccines Pediatric Vaccines for Coronavirus account for a significant market share.
  • Hence, amidst the pandemic, the global market for Pediatric vaccines declined in 2020 as most healthcare personal were busy in COVID-19 management.

Macro-Eyes selected by the Vaccine Confidence Fund to Boost Vaccination Confidence through Social Media

Retrieved on: 
Wednesday, January 26, 2022 - 10:00am

The Vaccine Confidence Fund (VCF) is the flagship program of the Alliance for Advancing Health Online (AAHO) , whose members include the CDC Foundation , the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank , Merck & Co ., and Facebook.

Key Points: 
  • The Vaccine Confidence Fund (VCF) is the flagship program of the Alliance for Advancing Health Online (AAHO) , whose members include the CDC Foundation , the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank , Merck & Co ., and Facebook.
  • "Building confidence in vaccination is critical to reducing vaccine hesitancy, which threatens to stall and even reverse progress made in combating vaccine-preventable diseases worldwide," said John H. Markels, President, Merck Vaccines.
  • "Supporting the public health efforts to increase vaccine confidence has been our top priority," said KX Jin, Facebook 's Head of Health.
  • The Vaccine Confidence Fund, financially supported by Facebook and Merck & Co , is the first flagship program of the Alliance for Advancing Health Online (AAHO).

Macro-Eyes selected by the Vaccine Confidence Fund to Boost Vaccination Confidence through Social Media

Retrieved on: 
Wednesday, January 26, 2022 - 10:00am

The Vaccine Confidence Fund (VCF) is the flagship program of the Alliance for Advancing Health Online (AAHO) , whose members include the CDC Foundation , the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank , Merck & Co ., and Facebook.

Key Points: 
  • The Vaccine Confidence Fund (VCF) is the flagship program of the Alliance for Advancing Health Online (AAHO) , whose members include the CDC Foundation , the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank , Merck & Co ., and Facebook.
  • "Building confidence in vaccination is critical to reducing vaccine hesitancy, which threatens to stall and even reverse progress made in combating vaccine-preventable diseases worldwide," said John H. Markels, President, Merck Vaccines.
  • "Supporting the public health efforts to increase vaccine confidence has been our top priority," said KX Jin, Facebook 's Head of Health.
  • The Vaccine Confidence Fund, financially supported by Facebook and Merck & Co , is the first flagship program of the Alliance for Advancing Health Online (AAHO).

Kiteworks Protects Employee and Contractor PHI; Enables Compliance With HIPAA and Vaccine Mandates

Retrieved on: 
Wednesday, January 19, 2022 - 1:03pm

In doing so, Kiteworks enables organizations to protect sensitive PHI and comply with the Health Insurance Portability and Accountability Act (HIPAA) and other privacy regulations.

Key Points: 
  • In doing so, Kiteworks enables organizations to protect sensitive PHI and comply with the Health Insurance Portability and Accountability Act (HIPAA) and other privacy regulations.
  • It also provides a detailed audit trail that organizations can use to demonstrate compliance with both vaccine mandates and HIPAA.
  • While some broader federal mandates have seen recent setbacks, many vaccine requirements in the U.S. are being voluntarily initiated within individual businesses.
  • More than half (57%) of U.S. employers have, or plan to issue, vaccine mandates for employees.

XIFIN Expands by 54% in 2021 to Serve More Elements of Healthcare Industry & Meet Increasing Market Needs

Retrieved on: 
Tuesday, January 18, 2022 - 2:00pm

During 2021, XIFIN expanded its operations to Charleston, S.C., and acquired two companies in complimentary healthcare market segments, growing its staff to nearly 800 employees, a 54% increase in company size.

Key Points: 
  • During 2021, XIFIN expanded its operations to Charleston, S.C., and acquired two companies in complimentary healthcare market segments, growing its staff to nearly 800 employees, a 54% increase in company size.
  • In 2021, XIFIN launched the newest iterations of its cloud-based solutions, XIFIN RPM and XIFIN LIS.
  • XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare.
  • To learn more, visit www.XIFIN.com , follow XIFIN on Twitter and LinkedIn , or subscribe to the XIFIN blog .

Public Health Expert Kate Onyejekwe to Lead JSI's Washington Office

Retrieved on: 
Wednesday, January 19, 2022 - 1:05pm

WASHINGTON, Jan. 19, 2022 /PRNewswire/ --John Snow, Inc. (JSI), is proud to announce that Kate Onyejekwe has been appointed to the position of International Division Washington, DC, office director.

Key Points: 
  • WASHINGTON, Jan. 19, 2022 /PRNewswire/ --John Snow, Inc. (JSI), is proud to announce that Kate Onyejekwe has been appointed to the position of International Division Washington, DC, office director.
  • My passion has always been to engender strong health systems and facilitate equitable health services for all.
  • "My passion has always been to serve people and communities around the world to engender strong health systems, build resilience, and facilitate equitable health services for all.
  • This role provides an even greater platform for the International Division, and JSI as a whole, to continue to shape and advance the global public health agenda," said Onyejekwe.

Global Pharmaceutical Packaging Industry 2021 - Temperature-sensitive Packaging for New-generation Biologics Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, January 14, 2022 - 5:37pm

The "Global Pharmaceutical Packaging Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pharmaceutical Packaging Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale.
  • Therefore, local manufacturing deals, supply chain investments, and packaging innovation will continue to play important roles in the global push for immunization.
  • For the biopharma industry, positive long-term developments and growth opportunities can outweigh the detrimental short-term impacts of the ongoing pandemic.

Kroger Health Wins 2022 American Pharmacists Association Immunization Champion Award

Retrieved on: 
Wednesday, January 12, 2022 - 5:31pm

CINCINNATI, Jan. 12, 2022 /PRNewswire/ --Kroger Health, the healthcare division of The Kroger Co. (NYSE:KR), receives the 2022 American Pharmacists Association (APhA) Immunization Champion Award.

Key Points: 
  • CINCINNATI, Jan. 12, 2022 /PRNewswire/ --Kroger Health, the healthcare division of The Kroger Co. (NYSE:KR), receives the 2022 American Pharmacists Association (APhA) Immunization Champion Award.
  • The APhA Immunization Champion Award recognizes Kroger Health as being an organization that continuously advances the role of pharmacists as valued immunization administrators.
  • "It's undeniable that Kroger Health is one of America's leading healthcare organizations and we've taken on the responsibility to improve immunization rates across the country starting with our associates and patients," says Colleen Lindholz, president of Kroger Health.
  • Kroger Health will accept the 2022 APhA Immunization Champion Award in San Antonio, Texas in March.